Business

August 7, 2014 2:16 PM

Chimerix reports $11.7M loss in second quarter

Chimerix posted a $11.7 million loss in the second quarter but also raised significant funds to finance the development of its lead drug candidate, brincidofovir.

Related content

Comments

Videos

Today's Market

Nasdaq
Powered by Barchart

Editor's Choice Videos

Raleigh Top Jobs

View All Top Jobs